{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:47:27Z","timestamp":1773294447682,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40263-020-00725-5","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T12:02:42Z","timestamp":1591358562000},"page":"643-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dose Adjustment of Stimulants for Children with Attention-Deficit\/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses"],"prefix":"10.1007","volume":"34","author":[{"given":"Lindsey","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Sapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Stanislaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-2403","authenticated-orcid":false,"given":"Alison S.","family":"Poulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"725_CR1","doi-asserted-by":"crossref","unstructured":"Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2018.","DOI":"10.1038\/s41380-018-0116-3"},{"issue":"6","key":"725_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00004703-198912000-00005","volume":"10","author":"T Davy","year":"1989","unstructured":"Davy T, Rodgers CL. Stimulant medication and short attention span: a clinical approach. J Dev Behav Pediatr. 1989;10(6):313\u20138.","journal-title":"J Dev Behav Pediatr"},{"key":"725_CR3","doi-asserted-by":"crossref","unstructured":"Ching C, Eslick GD, Poulton AS. Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit\/hyperactivity disorder: a meta-analysis. JAMA Pediatr. 2019.","DOI":"10.1001\/jamapediatrics.2019.0905"},{"key":"725_CR4","unstructured":"NSW Ministry of Health. Criteria for the diagnosis and management of attention deficit hyperactivity disorder in children and adolescents (TG181\/9). 2016."},{"issue":"3","key":"725_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1207\/s15374424jccp1803_9","volume":"18","author":"W Pelham","year":"1989","unstructured":"Pelham W, Milich R, Murphy D, Murphy H. Normative data on the IOWA Conners teacher rating scale. J Clin Child Psychology. 1989;18(3):259\u201362.","journal-title":"J Clin Child Psychology"},{"issue":"2","key":"725_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00004583-200102000-00013","volume":"40","author":"B Vitiello","year":"2001","unstructured":"Vitiello B, Severe JB, Greenhill LL, et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry. 2001;40(2):188\u201396.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"725_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1687-9856-2012-30","volume":"2012","author":"A Poulton","year":"2012","unstructured":"Poulton A, Briody J, McCorquodale T, et al. Weight loss on stimulant medication: how does it affect body composition and bone metabolism? A prospective longitudinal study. Int J Pediatr Endocrinol. 2012;2012(1):30.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"725_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/YIC.0000000000000109","volume":"31","author":"AS Poulton","year":"2016","unstructured":"Poulton AS, Bui Q, Melzer E, Evans R. Stimulant medication effects on growth and bone age in children with attention-deficit\/hyperactivity disorder: a prospective cohort study. Int Clin Psychopharmacol. 2016;31(2):93\u20139.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"725_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1440-1754.2003.00107.x","volume":"39","author":"A Poulton","year":"2003","unstructured":"Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health. 2003;39(3):180\u20135.","journal-title":"J Paediatr Child Health"},{"key":"725_CR10","unstructured":"Carton L, Dondaine T, Deheul S, et al. Supervised off-label prescribing of methylphenidate in adult ADHD. Encephale. 2018."},{"issue":"4323","key":"725_CR11","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.337493","volume":"198","author":"RL Sprague","year":"1977","unstructured":"Sprague RL, Sleator EK. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science. 1977;198(4323):1274\u20136.","journal-title":"Science"},{"issue":"4","key":"725_CR12","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1542\/peds.2010-0086","volume":"126","author":"JC Blader","year":"2010","unstructured":"Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010;126(4):e796\u2013806.","journal-title":"Pediatrics"},{"key":"725_CR13","doi-asserted-by":"crossref","unstructured":"Poulton AS, Paterson R. Stimulant prescribing for attention deficit hyperactivity disorder (ADHD): what guides clinicians in their choice of an upper limit for dose titration? Australas Psychiatry. 2020:1039856220905298.","DOI":"10.1177\/1039856220905298"},{"issue":"12","key":"725_CR14","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jamapediatrics.2019.3814","volume":"173","author":"JE Dravland","year":"2019","unstructured":"Dravland JE. Effective stimulant dosing in attention-deficit\/hyperactivity disorder. JAMA Pediatr. 2019;173(12):1210\u201311.","journal-title":"JAMA Pediatr"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-020-00725-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00725-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T23:49:39Z","timestamp":1618530579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-020-00725-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s40263-020-00725-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"16 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr Poulton has received speakers bureau honoraria, CME activity, conference support and advisory panel payments from Shire; Dr Ross, Dr Sapre and Ms Stanislaus report no financial relationships with commercial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research was unfunded.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}